Co-Authors
This is a "connection" page, showing publications co-authored by Martina Fabris and Salvatore De Vita.
Connection Strength
0.279
-
Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6. J Med Virol. 2020 11; 92(11):2852-2856.
Score: 0.223
-
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care. J Clin Virol. 2020 08; 129:104444.
Score: 0.055